Analysis and Enlightenment of cGMP Warning Letters Sent by FDA to Chinese Pharmaceutical Manufacturers

CAO Linlin, QIAN Yating, ZHANG Qingsong, LI Haijian, XIAO Haoxiang, LIU Wei

PDF(2364 KB)
主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
Chinese Journal of Pharmaceuticals
PDF(2364 KB)
Chinese Journal of Pharmaceuticals ›› 2023, Vol. 54 ›› Issue (06) : 950-956. DOI: 10.16522/j.cnki.cjph.2023.06.017
Pharmaceutical Management & Information

Analysis and Enlightenment of cGMP Warning Letters Sent by FDA to Chinese Pharmaceutical Manufacturers

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 54(06): 950-956 https://doi.org/10.16522/j.cnki.cjph.2023.06.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2364 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉